Sofosbuvir and Daclatasvir Manufacturer
| Active Ingredient: | Sofosbuvir/Daclatasvir |
|---|---|
| Dosage Form: | Tablets |
| Available Strength: | 400mg+60mg |
| Packaging: | 28 tablets in bottle |
| Therapeutic Use: | Chronic hepatitis C virus (HCV) infection |
| Pack Insert/Leaflet: | Yes |
| Production Capacity: | 1 Million Bottle's/Month |
Reviews
There are no reviews yet.